Equities researchers at William Blair decreased their FY2025 earnings per share estimates for shares of Cheesecake Factory in ...

Research analysts at William Blair reduced their Q1 2025 earnings per share estimates for Dynavax Technologies in a report ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for Booz Allen Hamilton Holding (NYSE:BAH) ...

William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...

William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Cardiff Oncology (CRDF – Research Report). The company’s ...

Read about the Senate confirmation of Kelly Loeffler, a former senator from Georgia and businesswoman, as head of the Small ...

Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (the “Company”) today announced the commencement ...